Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up

References

• IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1–241
   PubMedGoogle Scholar
• Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 1990;50: 4737–4740.
   PubMed Web of Science ®Google Scholar
• Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2.
   PubMed Web of Science ®Google Scholar
• Haenszel W, Correa P, Cuello C, et al. Gastric cancer in Colombia. II. Case-control epidemiologic study of precursor lesions. J Natl Cancer Inst. 1976;57:1021–1026.
   PubMedGoogle Scholar
• Sipponen P, Kekki M, Haapakoski J, et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 1985;35:173–177.
   PubMed Web of Science ®Google Scholar
• Siurala M, Sipponen P, Kekki M. Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol Suppl. 1985;109:69–76.
   PubMedGoogle Scholar
• Valle J, Kekki M, Sipponen P, et al. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol. 1996;31:546–550.
   PubMed Web of Science ®Google Scholar
• Villako K, Kekki M, Maaroos HI, et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl. 1991;186:135–141.
   PubMedGoogle Scholar
• Kekki M, Ihamäki T, Saukkonen M, et al. Progression of gastritis at a population level. Comparison of a long-term follow-up with stochastic analysis of cross-sectional data. Scand J Gastroenterol. 1980;15:651–655.
   PubMed Web of Science ®Google Scholar
• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;323:1311–1315.
   Google Scholar
• Vohlonen I, Härkönen M, Malila N, et al. Biomarker screening on risk for stomach cancer. Cancer mortality in a 15-year follow-up of men with low serum pepsinogen in 1994–1996. To be published
   Google Scholar
• Samloff IM. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology. 1981;82:26–33.
   Web of Science ®Google Scholar
• Varis K, Sipponen P, Laxen F, et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia: Helsinki Gastritis Study Group. Scand J Gastroenterol. 2000;35:950–956.
   PubMed Web of Science ®Google Scholar
• Storskrubb T, Aro P, Ronkainen J, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol. 2008 43:1448–1455.
   PubMed Web of Science ®Google Scholar
• Samloff IM, Varis K, Ihamäki T, et al. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–209.
   PubMed Web of Science ®Google Scholar
• The Finnish Cancer Registry 2011. [Internet]. Available from: www.cancerregistry.fi.
   Google Scholar
• Fleiss JL. Statistical methods for rates and proportions. New York: Wiley; 1981.
   Google Scholar
• Bland JM, Altman DG. Statistics notes. Logarithms. BMJ. 1996;312:700.
   PubMed Web of Science ®Google Scholar
• Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343:d2304.
   PubMed Web of Science ®Google Scholar
• Agréus L, Kuipers EJ, Kupcinskas L, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol. 2012;47:136–147.
   PubMed Web of Science ®Google Scholar
• Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007;56:918–925.
   PubMed Web of Science ®Google Scholar
• Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008;57:298–305.
   PubMed Web of Science ®Google Scholar
• Kamangar F, Qiao YL, Blaser MJ, et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer. 2007;96:172–176.
   PubMed Web of Science ®Google Scholar
• Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006;98:1445–1452.
   PubMed Web of Science ®Google Scholar
• Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst. 2001;93:226–233.
   PubMedGoogle Scholar
• Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther. 1999;13:851–856.
   PubMed Web of Science ®Google Scholar
• Palli D, Masala G, Del Giudice G, et al. CagA + Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer. 2007;120:859–867.
   PubMed Web of Science ®Google Scholar
• Knekt P, Teppo L, Aromaa A, et al. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period. Int J Cancer. 2006;119:702–705.
   PubMed Web of Science ®Google Scholar
• Kokkola A, Rautelin H, Puolakkainen P, et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol. 2000;35:138–141.
   PubMed Web of Science ®Google Scholar